APA
Hijazien, S. H., ALSmadi, M. M., Alrabadi, A. S., Alzayadi, M. T. & Alsarhan, M. R. (2021). Erythromycin Ethylsuccinate versus Metclopramide in Pateints with Chronic Gastroparesis. IAR Journal of Medical Sciences, 2(1), None-None.
MLA
Hijazien, Sami H., et al. "Erythromycin Ethylsuccinate versus Metclopramide in Pateints with Chronic Gastroparesis." IAR Journal of Medical Sciences 2.1 (2021): None-None.
Chicago
Hijazien, Sami H., Mohammad M. ALSmadi, Aeham S. Alrabadi, Marwan T. Alzayadi and Majd R. Alsarhan. "Erythromycin Ethylsuccinate versus Metclopramide in Pateints with Chronic Gastroparesis." IAR Journal of Medical Sciences 2, no. 1 (2021): None-None.
Harvard
Hijazien, S. H., ALSmadi, M. M., Alrabadi, A. S., Alzayadi, M. T. and Alsarhan, M. R. (2021) 'Erythromycin Ethylsuccinate versus Metclopramide in Pateints with Chronic Gastroparesis' IAR Journal of Medical Sciences 2(1), pp. None-None.
Vancouver
Hijazien SH, ALSmadi MM, Alrabadi AS, Alzayadi MT, Alsarhan MR. Erythromycin Ethylsuccinate versus Metclopramide in Pateints with Chronic Gastroparesis. IAR Journal of Medical Sciences. 2021 Jan;2(1):None-None.